My bad—I must have been thinking about LEVP’s previously stated goal of developing a recombinant C1 inhibitor. (Is this still in the plans at VPHM?) Thanks for the correction.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”